GGrantIndex
← Leaderboards

Catherine Bowes Rickman

Duke University

$11,208,971
Attributed
$11,208,971
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $914.5K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,208,971 · 8

By mechanism

R01$9,628,482 · 5
P30$1,196,665 · 2
R21$383,824 · 1

Top collaborators

No co-investigators on record.

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Choroid

Research focus

ChoroidPathologyBlindnessCholesterolDepositionAge Related Macular DegenerationProteinsFatty Acid Glycerol EstersGenesDietSocioeconomicsMouse ModelPathogenesisAreaComplement Factor HElderlyAlternative Complement PathwayComplementComplement ActivationVariantComplement SystemLipidsFunctional DisorderAged

Grant awards (32)

Gene therapy targeting CFH and lipoprotein dynamics in AMD$675,193
R01 · FY2025 · EY · contact PI
Mass Spectrometry and Molecular Biology Module$239,333
P30 · FY2025 · EY · contact PI
Complement factor H modulates lipoprotein clearance in AMD$575,241
R01 · FY2024 · EY · contact PI
Mass Spectrometry and Molecular Biology Module$239,333
P30 · FY2024 · EY · contact PI
Complement factor H modulates lipoprotein clearance in AMD$575,241
R01 · FY2023 · EY · contact PI
Mass Spectrometry and Molecular Biology Module$239,333
P30 · FY2023 · EY · contact PI
Complement factor H modulates lipoprotein clearance in AMD$557,985
R01 · FY2022 · EY · contact PI
Mass Spectrometry and Molecular Biology Module$239,333
P30 · FY2022 · EY · contact PI
Complement factor H modulates lipoprotein clearance in AMD$557,985
R01 · FY2021 · EY · contact PI
Mass Spectrometry and Molecular Biology Module$239,333
P30 · FY2021 · EY · contact PI
Complement factor H modulates lipoprotein clearance in AMD$574,114
R01 · FY2020 · EY · contact PI
Innate immunity, lipoproteins and AMD progression$484,667
R01 · FY2019 · EY · contact PI
Innate immunity, lipoproteins and AMD progression$507,825
R01 · FY2018 · EY · contact PI
Innate immunity, lipoproteins and AMD progression$545,155
R01 · FY2017 · EY · contact PI
Innate immunity, lipoproteins and AMD progression$490,218
R01 · FY2016 · EY · contact PI
Complement and Pathogenic Mechanisms of AMD$437,134
R01 · FY2014 · EY · contact PI
Complement and Pathogenic Mechanisms of AMD$9,436
R01 · FY2014 · EY · contact PI
Complement and Pathogenic Mechanisms of AMD$372,875
R01 · FY2013 · EY · contact PI
Complement and Pathogenic Mechanisms of AMD$392,500
R01 · FY2012 · EY · contact PI
Complement and Pathogenic Mechanisms of AMD$392,500
R01 · FY2011 · EY · contact PI
The APOE TR Mouse: A Model for Elucidating Pathogenic Mechanisms of AMD$351,000
R01 · FY2010 · EY · contact PI
The APOE TR Mouse: A Model for Elucidating Pathogenic Mechanisms of AMD$351,000
R01 · FY2009 · EY · contact PI
Murine Age-related Macular Degeneration: Model of Known Human Risk Factors$189,345
R21 · FY2007 · EY · contact PI
AMD Model Based on Constellation of Known Human AMD Risk Factors$194,479
R21 · FY2006 · EY · contact PI
CHARACTERIZATION OF GENES IN NORMAL AND AMD RETINAS$100,100
R01 · FY2005 · EY
CHARACTERIZATION OF GENES IN NORMAL AND AMD RETINAS$385,000
R01 · FY2004 · EY
CHARACTERIZATION OF GENES IN NORMAL AND AMD RETINAS$385,000
R01 · FY2003 · EY
CHARACTERIZATION OF GENES IN NORMAL AND AMD RETINAS$100,100
R01 · FY2003 · EY
CHARACTERIZATION OF GENES IN NORMAL AND AMD RETINAS$385,000
R01 · FY2002 · EY
CHARACTERIZATION OF GENES IN NORMAL AND AMD RETINAS$380,183
R01 · FY2001 · EY
GENES IN NORMAL AND AMD RETINAS$33,772
R01 · FY2000 · EY
CHARACTERIZATION OF GENES IN NORMAL AND AMD RETINAS$9,258
R01 · FY2000 · EY